Nawal Ouzren

Nawal Ouzren is an experienced executive in the pharmaceutical and biotechnology sectors, currently serving as Chief Executive Officer and Director at Sensorion since April 2017, and as a Non Executive Director at Croda since February 2022. Nawal's previous roles include Non Executive Director at Arena Pharmaceuticals, Inc. prior to its acquisition by Pfizer, and Independent Director at Inventiva Pharma. Nawal has held significant positions at Shire as Group Vice President for Rare Genetic Diseases and at Baxalta as Hemophilia Franchise Head, as well as various leadership roles at Baxter International Inc. and GE. Nawal Ouzren holds a Master of Science in Chemical Engineering from Université de Technologie de Compiègne and a Master's degree in Chemical Engineering from Technische Universität Berlin.